Tofacitinib and Metformin Reduce the Dermal Thickness and Fibrosis in Mouse Model of Systemic Sclerosis

0
8
Researchers investigated the therapeutic efficacy of tofacitinib and metformin on IL-17 and transforming growth factor beta cytokines, skin fibrosis and inflammation in mouse model of systemic sclerosis.
[Scientific Reports]
Full Article